Effect of electrically mediated intratumor and intramuscular delivery of a plasmid encoding IFN α on visible B16 mouse melanomas

Technology in Cancer Research and Treatment

Volumn 1, Issue 3, 2002, Pages 205-209

  Heller, Loree C ^a   Ingram, Stephanie F ^a   Lucas, M Lee ^a   Gilbert, Richard A ^b   Heller, Richard ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b University of South Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER ADJUVANT THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG TISSUE LEVEL; ELECTRICITY; GENE THERAPY; GENETIC CODE; HUMAN; LIVER; MELANOMA B16; MOUSE; MUSCLE; NONHUMAN; PLASMID; PROTEIN EXPRESSION; SKIN; TUMOR GROWTH; TUMOR REGRESSION; ANIMAL; C57BL MOUSE; CANCER TRANSPLANTATION; CELL CULTURE; DISEASE MODEL; ELECTROSTIMULATION; EXPERIMENTAL MELANOMA; FEMALE; GENE TRANSFER; GENE VECTOR; GENETICS; TREATMENT OUTCOME;

ANIMALS; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INTERFERON-ALPHA; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; PLASMIDS; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 0036627876     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460200100305     Document Type: Article

References (30)

1. Legha, S. S. The Role of Interferon Alfa in the Treatment of Metastatic Melanoma, Semin. Oncol. 24, S4-24-S4-31 (1997).
2. Agarwala, S. S. and Kirkwood, J. M. Adjuvant Therapy of Melanoma, Semin. Surg. Oncol. 14, 302-310 (1998).
3. Fleischmann, C. M., Stanton, G. J., and Fleischmann, W. R., Jr. Enhanced in vivo Sensitivity to Interferon with in vitro Resistant B16 Tumor Cells in Mice. Cancer Immunol. Immunother 39, 148-154 (1994).
4. Wu, T. Y. and Fleischmann, W. R., Jr. Efficacy of B16 Melanoma Cells Exposed in vitro to Long-Term IFN-α Treatment (B16α Cells) as a Tumor Vaccine in Mice, J. Interferon Cytokine Res. 18, 829-839 (1998).
5. Kaido, T., Bandu, M.-T., Maury, C., Ferrantini, M., Belardelli, F, and Gresser, I. IFN-α1 Gene Transfection Completely Abolishes the Tumorigenicity of Murine B16 Melanoma Cells in Allogeneic DBA/2 Mice and Decreases Their Tumorigenicity in Syngeneic C57BL/6 Mice, Int. J. Cancer 60, 221-229 (1995).
6. Jaroszeski, M. J., Gilbert, R., Heller, R. Electrochemotherapy: An emerging drug delivery method for the treatment of cancer, Adv. Drug Del. Rev. 26, 185-197 (1997)
7. Heller, R., Gilbert, R., Jaroszeski, M. Clinical applications of electrochemotherapy, Adv. Drug Del. Rev. 35, 119-129 (1999).
8. Somiari, S., Glasspool-Malone, J., Drabick, J. J., Gilbert, R. A., Heller, R., Jaroszeski, M. J., and Malone, R. W. Theory and in vivo application of electroporative gene delivery, Mol. Ther. 2,178-187 (2000).
9. Heller, L. C. and Lucas, M. L. Delivery of plasmid DNA by in vivo electroporation, Gene Ther and Mol. Biol. 5, 50-55 (2000).
10. Titomirov A. V., Sukharev S, Kistanova E. In vivo electroporation and stable transformation of newborn mice by plasmid DNA, Biochim. Biophys. Acta 1088, 131-134 (1991).
11. Glasspool-Malone, J., Somiari, S., Drabick, J. J., Malone, R. W. Efficient nonviral cutaneous transfection. Mol. Ther. 2, 140-146 (2000).
12. Heller, R., Schultz, J., Lucas, M. L., Jaroszeski, M. J., Heller, L. C., Gilbert, R. A., Moelling, K., and Nicolau, C. Intradermal delivery of IL-12 plasmid DNA by in vivo electroporation, DNA and Cell Biol 20, 21-26 (2001).
13. Heller, R, Jaroszeski, M., Atkin, A., Moradpour, D., Gilbert, R., Wands, J., and Nicolau, C. In vivo gene electroinjection and expression in rat liver, FEBS Lett 389, 225-228 (1996).
14. Aihara H., Miyazaki J.-I. Gene transfer into muscle by electroporation in vivo, Nat Biotech 6, 867-870 (1998).
15. Mir, L. M., Bureau, M. F., Gehl, J., Rangara, R., Rouy, D., Caillaud, J.-M., Delaere, P., Branellec, D., Schwartz, B., and Scherman, D. High-efficiency gene transfer into skeletal muscle mediated by electric pulses, Proc. Natl. Acad. Sci., USA 96, 4262-4267 (1999).
16. Mathiesen I. Electropermeabilization of skeletal muscle enhances gene transfer in vivo, Gene Ther. 6, 508-514 (1999).
17. Vicat, J. M., Boisseau, S., Jourdes, P., Laine, M., Wion, D., Bouali Benazzouz, R., Benabid, A. L, and Berger, F. Muscle transfection by electroporation with high-voltage and short-pulse currents provides high-level and long-lasting gene expression, Hum. Gene Ther 11, 11: 909-916 (2000).
18. Maruyama, H., Sugawa, M., Moriguchi, Y., Imazeki, I., Ishikawa, Y., Ataka, K., Hasegawa, S., Ito Y., Higuchi, N., Kazama, J. J., Gejyo, F., and Miyazaki, J.-I. Continuous erythropoietin delivery by muscle-targeted gene transfer using in vivo electroporation, Hum. Gene Ther 11, 429-437 (2000).
19. Widera, G., Austin, M., Rabussay, D., Goldbeck, C., Barnett, S. W., Chen, M., Leung, L., Otten, G. R., Thudium, K., Selby, M. J., and Ulmer, J. B. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo, J. Immuno. 164, 4635-4640 (2000).
20. Li, S., Zhang, X., Xia, X., Zhou, L., Breau, R., Suen, J., and Hanna, E. Intramuscular electroporation delivery of IFN-α Gene Therapy for Inhibition of Tumor Growth Located at a Distant Site, Gene Ther. 8, 400-407 (2001).
21. Nishi, T., Yoshizato, K., Yamashiro, S., Takeshima, H., Sato, K., Hamada, K., Kitamura, I., Yoshimura, T., Saya, H., Kuratsu, J., and Ushio, Y. High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation, Cancer Res. 56, 1050-1055 (1996).
22. Rols, M.-P., Delteil, C., Golzio, M., Dumond, P., Cros, S., and Teissie, J. In vivo electrically mediated protein and gene transfer in murine melanoma, Nat. Biotech. 16, 168-171 (1998).
23. Heller, L., Jaroszeski, M. J., Coppola, D. Pottinger, C., Gilbert, R., and Heller, R. Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo, Gene Ther. 7, 826-829 (2000).
24. Niu, G., Heller, R., Catlett-Falcone, R., Coppola, D., Jaroszeski, M., Dalton, W., Jove, R., and Yu, H. Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo, Cancer Res. 59, 5059-5063 (1999).
25. Lohr, F., Lo, D. Y., Zaharoff, D. A., Hu, K., Zhang, X., Li, Y., Zhao, Y., Dewhirst, M. W., Yuan, F., and Li, C. Y. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation, Cancer Res. 61, 3281-3284 (2001).
26. Kishida, T., Asada, H., Satoh, E., Tanaka, S., Shinya, M., Hirai, H., Iwai, M., Tahara, H., Imunishi, J., and Mazda, O. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice, Gene Ther. 8, 1234-1240 (2001).
27. Heller, L. C., Pottinger, C., Jaroszeski, M. J., Gilbert, R., and Heller, R. In vivo electroporation of plasmids encoding GMCSF and interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long term antitumor immunity, Melanoma Res. 10, 577-583 (2000).
28. Horton, H. M., Anderson, D., Hernandez, P., Barnhart, K. M., Norman, J. A., and Parker, S. E. A Gene Therapy for Cancer using Intramuscular Injection of Plasmid DNA Encoding Interferon α. Proc. Natl. Acad. Sci. USA 96, 1553-158 (1999).
29. Gilbert, R., Jaroszeski, M. J., and Heller, R. Novel electrode designs for electrochemotherapy, Biochim. Biophys. Acta 1334, 9-14 (1997).
30. Lucas, M. L. and Heller, R. Immunomodulation by electrically enhanced delivery of plasmid DNA encoding IL-12 to murine skeletal muscle, Mol. Ther. 3, 47-53 (2001).